Editorial · 31 Dec 2025
EditorialPublished 30 Nov 2024
Fecal Microbiota Transplantation (FMT) for Metabolic Disorders Current Insights and Therapeutic Potential
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fecal microbiota transplantation (FMT) has emerged as a novel therapeutic approach for a variety of gastrointestinal and systemic conditions by restoring microbial diversity and modulating gut microbiota composition. Increasing evidence suggests that the gut microbiota plays a pivotal role in the pathogenesis of metabolic disorders, including obesity, type 2 diabetes (T2D), and non-alcoholic fatty liver disease (NAFLD). FMT, which involves transferring fecal matter from a healthy donor to a recipient, has been shown to influence metabolic homeostasis by altering gut microbiota composition, improving insulin sensitivity, and modulating inflammatory pathways. This review explores the mechanisms underlying the impact of FMT on metabolic health, summarizes the current clinical evidence on its efficacy in treating metabolic disorders, and discusses the challenges and future directions for FMT as a therapeutic strategy for metabolic diseases.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Health Science Journal.
Editorial · 31 Dec 2025
Digestive Balance: Maintaining a Healthy Gut for Optimal Digestion and Well-being
Editorial · 31 Dec 2025
Prebiotics: Exploring the Role of Dietary Components in Supporting Gut Health and Overall Wellness
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Science Journal
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Lillian Pemberton”
